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Abstract
Background: The three major soil-transmitted helminths (STH) Ascaris lumbricoides, Trichuris trichiura and Necator
americanus/Ancylostoma duodenale are among the most widespread parasites worldwide. Despite the global expansion of
preventive anthelmintic treatment, standard operating procedures to monitor anthelmintic drug efficacy are lacking. The
objective of this study, therefore, was to define the efficacy of a single 400 milligram dose of albendazole (ALB) against
these three STH using a standardized protocol.
Methodology/Principal Findings: Seven trials were undertaken among school children in Brazil, Cameroon, Cambodia,
Ethiopia, India, Tanzania and Vietnam. Efficacy was assessed by the Cure Rate (CR) and the Fecal Egg Count Reduction
(FECR) using the McMaster egg counting technique to determine fecal egg counts (FEC). Overall, the highest CRs were
observed for A. lumbricoides (98.2%) followed by hookworms (87.8%) and T. trichiura (46.6%). There was considerable
variation in the CR for the three parasites across trials (country), by age or the pre-intervention FEC (pre-treatment). The
latter is probably the most important as it had a considerable effect on the CR of all three STH. Therapeutic efficacies, as
reflected by the FECRs, were very high for A. lumbricoides (99.5%) and hookworms (94.8%) but significantly lower for T.
trichiura (50.8%), and were affected to different extents among the 3 species by the pre-intervention FEC counts and trial
(country), but not by sex or age.
Conclusions/Significance: Our findings suggest that a FECR (based on arithmetic means) of .95% for A. lumbricoides and
.90% for hookworms should be the expected minimum in all future surveys, and that therapeutic efficacy below this level
following a single dose of ALB should be viewed with concern in light of potential drug resistance. A standard threshold for
efficacy against T. trichiura has yet to be established, as a single-dose of ALB is unlikely to be satisfactory for this parasite.
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Introduction
The three major Soil-Transmitted Helminths (STH), Ascaris
lumbricoides (roundworm), Trichuris trichiura (whipworm) and Necator
americanus/Ancylostoma duodenale (the hookworms) are amongst the
most widespread parasites worldwide. An estimated 4.5 billion
individuals are at risk of STH infection and more than one billion
individuals are thought to be infected, of whom 450 million suffer
morbidity from their infection, the majority of who are children.
An additional 44 million infected pregnant women suffer
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significant morbidity and mortality due to hookworm-associated
anemia. Approximately 135,000 deaths occur per year, mainly
due to infections with hookworms or A. lumbricoides [1].
The most widely implemented method of controlling STH
infections is through periodic administration of anthelmintics.
Rather than aiming to achieve eradication, current control
programs are focused on reducing infection intensity and
transmission potential, primarily to reduce morbidity and avoid
mortality associated with the disease [2]. The benzimidazole (BZ)
drugs, i.e. albendazole (ALB) and mebendazole, are the most
widely used drugs for the control of STH. While both show broad-
spectrum anthelmintic activity, for hookworms a single dose of
ALB is more effective than mebendazole [3].
The scale up of chemotherapy programs that is underway in
various parts of Africa, Asia and South America, particularly
targeting school children, is likely to exert increasing drug pressure
on parasite populations, a circumstance that is likely to favor parasite
genotypes that can resist anthelmintic drugs. Given the paucity of
suitable alternative anthelmintics it is imperative that monitoring
programs are introduced, both to assess progress and to detect any
changes in therapeutic efficacy that may arise from the selection of
worms carrying genes responsible for drug resistance. The well
documented occurrence of resistance to anthelmintics in nematode
populations of livestock [4], highlights the potential for frequent
treatments used in chemotherapy programs to select drug resistant
worms. Such an eventuality threatens the success of treatment
programs in humans, both at individual and community levels [5].
Although some small scale studies [6,7], have suggested emerging
drug resistance in human STH, these studies should be interpreted
with some caution, since suboptimal efficacy could have been due to
factors other than drug resistance. Moreover, although for the BZ
drugs there are many published studies reporting the Cure Rate
(CR) and the Fecal Egg Count Reduction (FECR), the two most
widely used indicators for assessing the efficacy of an anthelmintic in
human medicine, comparison of such studies is difficult, largely
because there is no widely accepted standard operating procedure
for undertaking such trials [8]. Published studies are confounded by
methodological variations including treatment regimens, poor
quality of drugs, differing statistical analyses used to calculate
therapeutic efficacy, as well as a range of other problems in study
design, such as small sample size, diagnostic methods, variation in
pre-intervention infection intensities and confounding factors related
to geographical locations. Such variation among studies greatly
complicates direct comparison [3]. A World Health Organization-
World Bank (WHO-WB) meeting on ‘‘Monitoring of Drug Efficacy
in Large Scale Treatment Programs for Human Helminthiasis’’,
held in Washington DC at the end of 2007, highlighted the need to
closely monitor anthelmintic drug efficacy and to develop standard
operating procedures for this purpose. In a systematic meta-analysis
of published single-dose studies, Keiser and Utzinger [8], confirmed
that there was a paucity of high quality trials, and that the majority of
trials were carried out more than 20 years ago. They recommended
that well-designed, adequately powered, and rigorously implement-
ed trials should be undertaken to provide current data regarding the
efficacy of anthelmintics against the main species of STH. These
should be designed to establish benchmarks (including standard
operating procedures) for subsequent monitoring of drug resistance.
The objective of the present work was to validate a standard
protocol that has been developed for monitoring efficacy of
anthelmintics against STH. To give the study wide relevance, we
conducted the trial in seven populations in different geographic
locations in Brazil, Cameroon, Cambodia, Ethiopia, India,
Tanzania and Vietnam. In each of the study sites, different
epidemiologic patterns of infection prevail, including different
combinations of STH. We assessed the efficacy of a single dose
(400 mg) of ALB in terms of the CR and the FECR in school
children between 14 and 30 days following treatment. The
McMaster egg counting technique was used in a standardized
fashion, with rigorous quality control. Levecke et al. [9] reported
that the McMaster holds promise as a standardized method on
account of its applicability for quantitative screening of large
numbers of subjects. This method is the recommended method for
measuring fecal egg counts (FEC) when performing FECR for the
detection of anthelmintic resistance in veterinary medicine [10,11].
Methods
Study sites
This study was carried out in seven different countries covering
Africa (Cameroon, Ethiopia and Tanzania), Asia (Cambodia,
India and Vietnam) and South-America (Brazil). However, it is
important to note, that while we refer to individual countries to
identify results from particular trials, we do not make any
conclusions about any country as such. Here, names of countries
are used only to distinguish between 7 separate trials that were
conducted in 7 geographically disparate regions of the world. In
total ten study sites with varying STH and treatment history were
included. These seven STH endemic countries were selected
because of the presence of investigator groups with previous
extensive experience in the diagnosis and control of STH. Table 1
provides their specific locations (district/province/state) and
treatment history. Both species of hookworms (N. americanus and
A. duodenale) were present in all study sites in varying degree with
the exception of Brazil where only N. americanus was present.
Trial design
During the pre-intervention survey, school children aged 4 to 18
years at the different study sites were asked to provide a stool
sample. For the initial sampling the aim was to enroll at least 250
Author Summary
Soil-transmitted helminths (roundworms, whipworms and
hookworms) infect millions of children in (sub)tropical
countries, resulting in malnutrition, growth stunting,
intellectual retardation and cognitive deficits. Currently,
there is a need to closely monitor anthelmintic drug
efficacy and to develop standard operating procedures, as
highlighted in a World Health Organization–World Bank
meeting on ‘‘Monitoring of Drug Efficacy in Large Scale
Treatment Programs for Human Helminthiasis’’ in Wash-
ington DC at the end of 2007. Therefore, we have
evaluated the efficacy of a commonly used treatment
against these parasitic infections in school children in
Africa, Asia and South-America using a standardized
protocol. In addition, different statistical approaches to
analyzing the data were evaluated in order to develop
standardized procedures for data analysis. The results
demonstrate that the applied treatment was highly
efficacious against round- and hookworms, but not against
whipworms. However, there was large variation in efficacy
across the different trials which warrants further attention.
This study also provides new insights into the statistical
analysis of efficacy data, which should be considered in
future monitoring and evaluation studies of large scale
anthelmintic treatment programs. Finally, our findings
emphasize the need to update the World Health
Organization recommended efficacy threshold for the
treatment of STH.
Efficacy of Albendazole against STH in Children
www.plosntds.org 2 March 2011 | Volume 5 | Issue 3 | e948
infected children with a minimum of 150 eggs per gram of feces
(EPG) for at least one of the STH. This sample size was selected
based on statistical analysis of study power, using random
simulations of correlated over-dispersed FEC data reflecting the
variance-covariance structure in a selection of real FEC data sets.
This analysis suggested that a sample size of up to 200 individuals
(a=0.05, power = 80%) was required to detect a 10 percentage
point drop from a null efficacy of, 80% (mean percentage FEC D
per individual) over a wide range of infection scenarios. Standard
power analyses for proportions also indicated that the detection of
a ,10 percentage point drop from a null cure rate required
sample sizes up to 200 (the largest samples being required to detect
departures from null efficacies of around 50%). Given an
anticipated non-compliance rate of 25%, a sample of 250
individuals with .150 EPG pre-treatment was therefore consid-
ered necessary at each study site.
Fecal samples were processed using the McMaster technique
(analytic sensitivity of 50 EPG) for the detection and the
enumeration of infections with A. lumbricoides, T. trichiura and
hookworms [9]. None of the samples were preserved. Samples
which could not be processed within 24 hours were kept at 4uC. A
single dose of 400 mg ALB (Zentel) from the same manufacturer
(GlaxoSmithKline Pharmaceuticals Limited, India) and same lot
(batch number: B.Nu: L298) was used at all trial sites. No placebo
control subjects were included in the trial for ethical and
operational reasons. Between 14 to 30 days after the pre-
intervention survey, stool samples were collected from the treated
subjects and processed by the McMaster technique. All of the trials
were carried out in a single calendar year (2009). Subjects who
were unable to provide a stool sample at follow-up, or who were
experiencing a severe concurrent medical condition or had
diarrhea at time of the first sampling, were excluded from the
study. The participation, the occurrence of STH and sample
submission compliance for pre- and post-intervention surveys are
summarized in Figure 1.
The McMaster counting technique
The McMaster counting technique (McMaster) was based on
the modified McMaster described by the Ministry of Agriculture,
Fisheries and Food (UK; 1986) [12]. Two grams of fresh stool
samples were suspended in 30 ml of saturated salt solution
(density = 1.2). The suspension was poured three times through a
wire mesh to remove large debris. Then 0.15 ml aliquots were
added to each of the 2 chambers of a McMaster slide. Both
chambers were examined under a light microscope using a 100x
magnification and the FEC for each helminth species was obtained
by multiplying the total number of eggs by 50.
Statistical analysis
The efficacy of the treatment for each of the three STH was
evaluated qualitatively based on the reduction in infected children
(CR) and quantitatively based on the reduction in fecal egg counts
(FECR). The outcome of the FECR was calculated using three
formulae. The first two formulae were based on the mean
(arithmetic/geometric) of the pre- and post-intervention fecal egg
count (FEC) ignoring the individual variability, whereas the third
formula represented the mean of the reduction in the FEC per
subject. The latter is the only quantitative indicator of efficacy for
which the importance of confounding factors can be assessed by
statistical analysis.
FECR(1)~100%|
arithmetic mean(pre-intervention FEC){arithmetic mean(post-intervention FEC)
arithmetic mean(pre-intervention FEC)
FECR(2)~100%|
geometric mean(pre-intervention FEC){geometric mean(post-intervention FEC)
geometric mean(pre-intervention FEC)
FECR(3)~100%|
arithmetic mean
pre-interevention FEC½ { post-intervention FEC½ 
pre-interevention FEC
 
The CR and the FECR (1-3) outputs were calculated for the
different trials, both sexes, age classes (A: 4–8 years; B: 9–13 years
and C: 14–18 years) and for the level of egg excretion intensity at
the pre-intervention survey. These levels corresponded to the low,
moderate and high intensities of infection as described Montresor
et al. [13] For A. lumbricoides these were 1–4,999 EPG, 5,000–
49,999 EPG and.49,999 EPG; for T. trichiura these levels were 1–
999 EPG, 1000–9,999 EPG and.9,999 EPG; and for hookworms
these were 1–1,999 EPG, 2,000–3,999 EPG and .3,999 EPG,
respectively.
In addition, the robustness of the three FECR formulae was
explored by comparing the FEC reduction rate obtained from all
Table 1. The location and treatment history of the ten study sites.
Country District/Province/State Treatment history
Brazil Minas Gerais LSAT since 2007 (ALB)
Cambodia Kratie LSAT since 1997, last in 2007 (MBD)
Cameroon Loum LSAT (MBD/ALB) since 1999, last in 2008 (MBD)
Yoyo No LSAT
Ethiopia Jimma No LSAT
India Vellore LSAT, since 2001, last in 2008 (ALB)
Thiruvanamalai No LSAT
Tanzania (Zanzibar) Pemba Island LSAT since 1994, last in 2006 (PZQ, IVM, ALB)
Vietnam Tha´i Nguyeˆn LSAT since 2005
Tuyeˆn Quang No LSAT
LSAT: large scale anthelmintic treatment, MBD: mebendazole, PZQ: praziquantel, IVM: ivermectine, ALB: albendazole.
doi:10.1371/journal.pntd.0000948.t001
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samples containing STH and those obtained from samples
containing more than 150 EPG as recommended in the
anthelmintic resistance guidelines of the World Association for
the Advancement of Veterinary Parasitology [9]. Finally, putative
factors affecting the CR and the FECR (3) were evaluated. For the
CR, generalized linear models (binomial error) were built with the
test result (infected /uninfected) as the outcome, ‘trial’ (7 levels:
trials in Brazil, Cambodia, Cameroon, Ethiopia, India, Tanzania
and Vietnam) and ‘sex’ (2 levels: female and male) as factors, and
‘age’ and the log transformed pre-intervention FEC as covariates.
Full factorial models were evaluated by the backward selection
procedure using the likelihood ratio test of x2. Finally, the CR for
each of the observed values of the covariate and factor was
calculated based on these models (The R Foundation for Statistical
Computing, version 2.10.0 [14]). For analysis of the data from
FECR (3), non-parametric methods were used, because models
based on parametric statistics, even with negative binomial error
structures, or based on transformed data would not converge
satisfactorily as a consequence of the high proportion of FEC with
zero EPG. Hence, the impact of the factors ‘trial’ and ‘sex’ were
assessed by the Kruskal-Wallis test (for more than 2 group
comparisons) and the Mann-Whitney U test, respectively. The
correlation between the outputs of FECR (3) and the covariates
(age and pre-intervention FEC) was estimated by the Spearman
rank order correlation coefficient (SAS 9.1.3, SAS Institute Inc.;
Cary, NC, USA).
Ethics statement
The overall protocol of the study was approved by the Ethics
committee of the Faculty of Medicine, Ghent University (Nr
B67020084254) and was followed by a separate local ethical
approval for each study site. For Brazil, approval was obtained
from the Institutional Review Board from Centro de Pesquisas
Rene´ Rachou (Nr 21/2008), for Cambodia from the National
Ethic Commitee for Health Research, for Cameroon from the
National Ethics Committee (Nr 072/CNE/DNM08), for Ethiopia
from the Ethical Review Board of Jimma University, for India
from the Institutional Review Board of the Christian Medical
College (Nr 6541), for Tanzania (Nr 20) from the Zanzibar Health
Research Council and the Ministry of Health and Social Welfare,
for Vietnam by the Ministry of Health of Vietnam. An informed
consent form was signed by the parents of all subjects included in
the study. This clinical trial was registered under the Clinical-
Trials.gov Identifier NCT01087099.
Figure 1. The participation, occurrence of STH and sample submission compliance for pre- and post-intervention surveys. Subjects
who were not able to provide a sample for the follow-up, or who were experiencing a severe current medical condition or had diarrhea at the time of
the first sampling were excluded from the trial.
doi:10.1371/journal.pntd.0000948.g001
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Results
The cure rate (CR)
Overall, the highest CRs were observed for A. lumbricoides
(98.2%), followed by hookworm (87.8%) and T. trichiura (46.6%).
However, as shown in Table 2, the CRs varied across the different
trials, age classes and pre-intervention FEC levels. The differences
in CRs between trials were most pronounced for T. trichiura,
ranging from 21.0 (Tanzania) to 88.9% (India). The T. trichiura
CRs of 100% for the trials in Brazil and Cambodia are not
considered here as they were based on only 1 and 2 individuals,
respectively. For hookworms and A. lumbricoides, the CRs varied
from 74.7 (India) to 100% (Vietnam) and from 96.4 (Tanzania) to
99.3% (Ethiopia and Cameroon), respectively. The CRs for A.
lumbricoides in Cambodia (100%) and India (95.2%) are not
considered here as they were based on fewer than 50 individuals.
The CRs increased over the three age classes (A. lumbricoides: 95.8
to 100%; T. trichiura: 44.7 to 54.1%), except for hookworms where
the CRs ranged from 86.1 to 88.3, and then to 87.5%. For each of
the three STH, there was a decline in the CR with increasing
levels of infection intensities at the pre-intervention survey. The
largest drop was observed for T. trichiura, which decreased from
53.9 to 12.5%. For the two other STH, the drop in the CR was
less pronounced, ranging from 88.6 to 76.9% for hookworms and
only from 98.3 to 95% for A. lumbricoides. The observed differences
between sexes were negligible for all three STH.
Differences in CR by trial, age and pre-intervention FEC are
illustrated in Figure 2. The variability in the CR of the three
parasites was significantly associated with these three factors
(predictive value .75%). The pre-intervention FEC was
probably the most important as it had a considerable effect on
the CR of A. lumbricoides (x21 = 4.14, p,0.05), T. trichiura
(x21 = 66.3, p,0.0001) and hookworms (x
2
1 = 11.9, p,0.001).
Age only contributed to variation in the CR of A. lumbricoides
(x21 = 6.8, p,0.01). Differences among the trials (countries) in the
CR were observed for T. trichiura (x23 = 33.8, p,0.0001) and
hookworms (x26 = 35.1, p,0.0001), but not for A. lumbricoides. In
addition, there was an interaction between the pre-intervention
FEC for A. lumbricoides (x21 = 4.7, p,0.05) and for T. trichiura
(x23 = 18.4, p,0.0005) with age and trial (country) respectively
(lines cross one another). The impact of pre-intervention FEC on
the CR of A. lumbricoides was more pronounced for older
individuals than younger ones. For T. trichura the effect of pre-
intervention FEC varied considerably across the trials conducted
in the different countries, particularly for the trial in Ethiopia
where the CR dropped from almost 100 to nearly 0% as the pre-
intervention FEC increased.
Comparison of different formulae for assessing FECR
The pre-intervention FEC for the different STH ranged from
50 to 170,500 EPG for A. lumbricoides (arithmetic mean=6877
EPG), from 50 to 23,200 EPG for T. trichiura (arithmetic
mean=824 EPG) and from 50 to 13,800 EPG for hookworm
(arithmetic mean= 650 EPG). The data in Table 3 show that there
was considerable variation in the arithmetic means of the FEC
from the trial groups in the 7 participating countries for each of the
three STH species. As illustrated in Figure 3, pre-intervention
FEC were highly aggregated among the subjects, and high FEC
were only observed in relatively few subjects.
The FEC reduction rate calculated using all three formulae
(based on FECR 1-3) in turn for A. lumbricoides, T. trichiura and
hookworms across the 7 trials (countries), age classes, sexes and
pre-intervention infection intensities are summarized in Table 4.
Overall, the FEC reduction rate for FECR(1) was the highest for
A. lumbricoides (99.5%), followed by hookworm (94.8%) and T.
trichiura (50.8%). However, there was considerable variation in the
FEC reduction rate among the 7 trials, age classes and infection
intensities at pre-intervention survey. For A. lumbricoides, the FEC
reduction rate remained roughly unchanged over these variables,
only ranging from 97.8 to 100%. This contrasts with T. trichiura,
for which the FEC reduction rate differed between the trials (from
39.2 [Cameroon] to 92.4% [Ethiopia]), age classes (from 45.4 [B]
to 62.7% [A]) and pre-intervention infection intensity (from 40.0
[high] to 58.7% [moderate]). There was no difference in the FEC
reduction rate between the sexes. For hookworms, only small
differences in the FEC reduction rate were observed between the
trials, ranging from 87.1 [India] to 100% [Vietnam]. However,
there were only negligible differences between the age classes (from
94.7 [B] to 96.4% [C]).
Compared to the results of FECR (1), the outputs of FECR (2)
resulted in higher values for all three STH, except for A.
lumbricoides where the FEC reduction rate already showed a ceiling
effect (100%). Considerable variation in the FEC reduction rate
(FECR (2)) occurred with T. trichiura among the trials (from 82.6
[Tanzania] to 99.1% [Ethiopia]) and pre-intervention infection
intensity (from 88.6 [high] to 94.3% [low]). For hookworms, the
differences between the trials were virtually negligible, all
indicating a potent effect just short of the maximum 100% (FECR
(2) .99.3%).
The results of FECR (3) mostly yielded comparable or lower
values than those from FECR (1). The low values (sometimes
negative) can be explained by subjects for whom the post-
Table 2. The cure rate (CR) for treatment with a single dose
of albendazole against soil-transmitted helminths.
A.
lumbricoides T. trichiura Hookworms
n CR (%) N CR (%) n CR (%)
Country
Brazil 50 98.0 1* 100 52 88.5
Cambodia 5* 100 2* 100 127 87.4
Cameroon 298 99.3 386 47.4 140 87.1
Ethiopia 151 99.3 105 85.7 91 98.9
India 21* 95.2 18* 88.9 95 74.7
Tanzania 279 96.4 396 21.0 349 86.8
Vietnam 148 98.6 138 81.2 58 100
Age class
A (4–8) 215 95.8 219 44.7 173 86.1
B (9–13) 669 98.8 753 46.3 643 88.3
C (14–18) 68 100 74 54.1 96 87.5
Sex
Female 462 98.1 503 48.5 393 89.1
Male 490 98.4 543 44.8 519 86.9
Pre-intervention infection intensity
Low 662 98.3 823 53.9 859 88.6
Moderate 270 98.1 215 19.5 40 75.0
High 20 95.0 8 12.5 13 76.9
Total 952 98.2 1046 46.6 912 87.8
*Due to the low number of infected subjects (,50), the trials conducted in
these countries were excluded from further analysis.
doi:10.1371/journal.pntd.0000948.t002
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intervention FEC exceeded the pre-intervention FEC. These
subjects contributed to a negative FEC reduction rate which had a
significant impact on the final FEC reduction rate calculated with
FECR (3). This became apparent in the FEC reduction rate for A.
lumbricoides, where a Cameroonian male subject of 7 years with a
pre-intervention FEC of 100 and a post-intervention FEC of
22,050 EPG, contributed markedly to lowering the overall values
for the data-set from the trial in Cameroon (FECR (1): 99.2%;
FECR (3): 26.0%). This lowering of FECR (3) compared to FECR
(1) for A. lumbricoides also occurred with age class A (FECR (1):
98.9%; FECR (3): 22.7%) and the low pre-intervention infection
intensity level (FECR (1): 97.8%; FECR (3): 66.6%), but not for
the remaining variables. The number of negative individual FEC
reduction rates, and the magnitude of the difference between pre-
and post-intervention FEC, both contributed to the discrepancies
found for T. trichiura (176 subjects) and hookworms (10 subjects).
Figure 2. The estimated impact of age, fecal egg count and trial on the cure rate. The estimated impact of age, fecal egg count (FEC) and
trial (country) on the cure rate of A. lumbricoides (A), T. trichiura (B) and hookworms (C) derived from a generalized linear models (binomial error).
doi:10.1371/journal.pntd.0000948.g002
Table 3. The arithmetic means of fecal egg counts of soil-transmitted helminths across the seven trials (countries).
A. lumbricoides T. trichiura Hookworms
N
Arithmetic mean
(min-max) n
Arithmetic mean
(min-max) n
Arithmetic mean
(min-max)
Brazil 50 9230
(100–51250)
1 50 52 617
(50–2900)
Cambodia 5 1420
(50–6600)
2 175
(50–300)
127 585
(50–4400)
Cameroon 298 12085
(50–170500)
386 1023
(50–23200)
140 567
(50–13800)
Ethiopia 151 3443
(100–62500)
105 420
(100–5200)
91 326
(100–1650)
India 21 2927
(50–13100)
18 305
(50–1100)
95 662
(100–3000)
Tanzania 279 4279
(50–55750)
396 924
(50–6650)
349 867
(50–6950)
Vietnam 148 4741
(50–53000
138 371
(50–4600)
58 205
(50–2500)
Total 952 6877
(50–170500)
1046 824
(50–23200)
912 650
(50–13800)
doi:10.1371/journal.pntd.0000948.t003
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Robustness of FECR formulae
Table 5 summarizes the FEC reduction rates restricted to
samples of more than 150 EPG indicating that the results of FECR
(1) and FECR (2) remained roughly unchanged. The values from
FECR (3) increased and were mostly comparable with those
obtained by FECR (1). This change in the results of FECR (3) is
due to the exclusion of negative individual FEC reduction rates
which mostly occurred among the subjects with low pre-
intervention FEC (see also Table 4). Differences of more than
5% between the results of FECR (3) and FECR (1) were limited to
T. trichiura (country: Cameroon, India, Tanzania and Vietnam;
age class: A and C).
Factors associated with FECR
The assessment of putative factors affecting the results from
FECR (3) was restricted to samples containing more than 150
EPG. Due to the limited variation in the FEC reduction rates
(FECR (3)) of A. lumbricoides across the different variables, this
species was not analyzed further. Also, because of the limited
number of infected subjects (,50), the trials in Brazil, Cambodia
and India were excluded from analyses of T. trichiura. For
hookworms, and for the same reasons, subjects from the trials in
Brazil and Vietnam were not included. Significant differences in
the FEC reduction rates between the trials were found for both T.
trichiura (x23 = 117.3, p,0.0001) and hookworms (x
2
4 = 20.2,
p=0.0005). High pre-intervention FEC of T. trichiura yielded
lower FEC reduction rates (3) (Rs =20.18, n= 701, p,0.0001),
but this was not found for hookworm (Rs =20.04, n= 601,
p = 0.34). In addition, there was an interaction between the pre-
intervention FEC of T. trichiura and trial (country), reflected in the
negative correlations in the trials in Cameroon (Rs =20.28,
n = 233, p,0.0001), and Ethiopia, (Rs =20.34, n= 72,
p = 0.0034), but a positive correlation for the trial in Tanzania
(Rs = +0.28, n = 325, p,0.0001) and a non-significant correlation
for the trial in Vietnam (Rs =20.07, n = 71, p = 0.58). Host sex
and age did not contribute significantly to variation of the results
of (FECR (3)) in any of the STH examined.
Discussion
To our knowledge, the present study is the first to evaluate drug
efficacy for STH in school children across different endemic
regions using a protocol which was standardized in terms of the
treatment (a single-oral 400 mg dose of ALB originating from the
same batch), the follow up (between 14 and 30 days after) and the
detection technique (the McMaster counting technique). More-
over, efficacy was evaluated by both the CR and the FECR, and
compared statistically between the seven trials which took place in
geographically disparate parts of the world.
Overall, this study supports previous reports that indicated that
single dose ALB treatment is most effective for infection with A.
lumbricoides, followed by hookworm, but is relatively ineffective for
T. trichiura, confirming the efficacy studies reviewed by Bennet and
Guyatt [3], and by Keiser and Utzinger [8]. The low efficacy
observed for T. trichiura compared to the two other STH, is in
keeping with previous studies, where a 3-day dose schedule of ALB
has been shown to be necessary to achieve acceptable therapeutic
efficacy [3].
At present, the most commonly reported indicator of drug
efficacy in this field is the CR [3]. Our results support the view that
the CR should not be the recommended parameter, as it is
sensitive to variation in the intensity of infection before treatment.
The CRs declined in all three STH with increasing intensity of
infection (FEC) at the pre-intervention survey. Hence, comparison
between populations (countries, villages, schools, etc.) differing in
pre-intervention FEC are guaranteed to arrive at different
conclusions about drug efficacy. Differences in the outputs of
Figure 3. The distribution of the fecal egg count of soil-transmitted helminths. The distribution of the fecal egg count (FEC) of A.
lumbricoides (A), T. trichiura (B) and hookworms (C). The absolute values of the median, the 2.5th and 97.5th percentile (%) are provided. In addition,
these values are represented as solid (median) and dashed lines (2.5 and 97.5%).
doi:10.1371/journal.pntd.0000948.g003
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calculations based on processing quantitative data in different ways
also showed variation that requires careful review if standard
operating procedures for data processing are to be adopted. The
observation that therapeutic efficacies based on arithmetic means
were mostly lower than those based on geometric means is in
agreement with other studies [15], and arises because the
arithmetic means captures the variation more effectively, while
the geometric means compress the data such that efficacies are
highly overestimated. Our exploratory analysis of different
statistical approaches for analyzing data also indicates that FECR
based on individuals was highly affected by excluding subjects with
pre-intervention FEC below 150 EPG. Therefore, we conclude
that the group based formula using an arithmetic mean is the best
summary statistic to employ in analysis of therapeutic efficacy in
future large scale drug administration trials, since it represents a
robust indicator that is sensitive to changes in drug efficacy.
The efficacy (CR and FEC reduction rate) varied widely across
the trials, except for A. lumbricoides. Possible explanations for the
observed differences include (1) treatment history, (2) geographic
differences within STH species, (3) fecal consistency and (4) diet. It
is therefore pertinent to comment on each. Although the lowest
efficacies for T. trichiura (Cameroon and Tanzania) and hook-
worms (India) were obtained in countries with a treatment history,
the observed low efficacies are not likely to be attributable to large
scale anthelmintic treatment in Cameroon and India. In these
countries, a comparison between different study sites with a history
of large scale anthelmintic treatment (Cameroon: Loum; India:
Vellore) and without such a history (Cameroon: Yoyo; India:
Thiruvanamalai) indicated that these large scale programs did not
result in a reduced efficacy compared to sites were they were
absent (data not shown and to be published separately). For
Tanzania, the impact of large scale anthelmintic treatment
programs could be ruled out, as studies before and during these
interventions have shown similar drug efficacy figures for T.
trichuria [16,17].
Current molecular studies indicate that geographical differences
exist within STH species [18,19]. For T. trichiura varying
anthelmintic efficacy has been suggested to be attributable to the
presence/absence of the b-tubulin codon 200 polymorphism that
has been linked to BZ resistance [20]. Strain differences have been
demonstrated in some species with different drug tolerance as
assessed both by efficacy and molecular studies [20,21]. Never-
theless, the exact impact of genetic differences within the 3 STH in
this study on the efficacy of specific anthelmintics remains
speculative. Of note, even at a higher taxonomic level, information
on the relative therapeutic efficacy of a single dose ALB on N.
americanus and A. duodenale is scarce, this despite the distinct and
well known biological differences between these hookworms [22-
24]. FEC was calculated in the current study without compensa-
tion for fecal consistency. It is well recognized that well-formed
stools can concentrate helminth eggs, compared to looser or
diarrheic feces where they are diluted [25], thus confounding
assessment of drug efficacy. Finally, the diet of subjects varied
considerably across the seven participating countries. Differences
in the quality of food consumed would have created differences in
fat and roughage content and/or increased the rate of passage of
Table 4. Fecal egg count reduction across different countries, age classes, sexes and pre-intervention intensities.
A. lumbricoides T. trichiura Hookworms
n
FECR
(1)
(%)
FECR
(2)
(%)
FECR
(3)
(%) n
FECR
(1)
(%)
FECR
(2)
(%)
FECR
(3)
(%) n
FECR
(1)
(%)
FECR
(2)
(%)
FECR
(3)
(%)
Country
Brazil 50 100.0 100.0 100.0 1* 100.0 98.0 100.0 52 97.5 99.6 97.8
Cambodia 5* 100.0 99.6 100.0 2* 100.0 99.2 100.0 127 97.6 99.5 96.6
Cameroon 298 99.2 100.0 26.0 386 39.2 93.0 34.7 140 93.0 99.2 91.9
Ethiopia 151 100.0 99.9 100.0 105 92.4 99.1 93.1 91 99.7 99.6 99.9
India 21* 98.9 99.8 99.7 18* 74.5 98.9 92.1 95 87.1 99.2 81.6
Tanzania 279 100.0 99.9 99.9 396 52.0 82.6 236.2 349 95.3 99.6 92.6
Vietnam 148 100.0 99.9 99.9 138 92.3 98.8 86.4 58 100.0 99.3 100.0
Age class
A (4–8) 215 98.9 100.0 22.7 219 62.7 94.0 32.2 173 94.8 99.5 95.2
B (9–13) 669 99.8 99.9 100.0 753 45.4 93.8 16.3 643 94.7 99.5 92.3
C (14–18) 68 100.0 100.0 100.0 74 59.6 94.7 45.4 96 96.4 99.5 97.0
Sex
Female 462 100.0 99.9 99.9 503 50.3 94.6 9.3 393 95.2 99.5 94.2
Male 490 99.0 99.9 54.9 543 51.2 93.2 33.2 519 94.5 99.5 92.8
Pre-intervention infection intensity
Low 662 97.8 99.9 66.6 823 40.2 94.3 11.9 859 93.9 99.4 93.2
moderate 270 100.0 100.0 100.0 215 58.7 92.2 58.7 40 97.6 99.9 97.1
High 20 99.5 100.0 99.6 8 40.0 88.6 40.1 13 95.9 99.9 96.4
Total 952 99.5 99.9 76.8 1046 50.8 93.9 21.7 912 94.8 99.5 93.4
FECR(1): group based and arithmetic mean; FECR(2): group based and geometric mean; FECR(3): individual based and arithmetic.
*Due to the low number of infected subjects (,50), the trials conducted in these countries were excluded from further analysis.
doi:10.1371/journal.pntd.0000948.t004
Efficacy of Albendazole against STH in Children
www.plosntds.org 8 March 2011 | Volume 5 | Issue 3 | e948
substances through the gastrointestinal tract. This may have
reduced the period over which ALB could have acted on the
parasites, thereby reducing efficacy [26-28].
Kopp et al. [29] demonstrated that a reduction in adult canine
hookworm (A. caninum) counts following chemotherapy did not
always yield a reduction in FEC, due to an increase in fecundity
among the small residual worm population that survived the
anthelmintic treatment (i/e., density dependent fecundity), conse-
quently confounding the FECR. As described by Kotze and Kopp
[30], density dependent effects could be manifested in a FECR as
a reduced drug efficacy for subjects with higher pre-intervention
FEC. However, this did not occur in the present study for A.
lumbricoides and hookworm. For T. trichiura, the efficacy did
decrease with increasing pre-intervention FEC, but this should
be interpreted with some caution. This effect was not consistent
across the different trials (e.g., no correlation in Vietnam but a
positive correlation in Tanzania), suggesting that other factors as
discussed above may have confounded this result. It is also possible
that increases in FEC may have arisen because of the inability of
ALB to cure infections during the pre-patent period (with an onset
of patency after the pre-intervention egg count time point). This is
a complication that cannot be avoided in studies taking place in
endemic areas where transmission occurs daily because of soil and
food contaminated with infective stages of the parasites, and is not
interrupted in the population during the period of study. Finally, a
negative correlation between the FEC and efficacy is expected, as
the probability of having a FEC of zero after treatment in the
follow-up survey, consequently a FECR of 100%, will be higher
for low FEC than for high FEC before the administration of the
drug.
Our findings emphasize a need to adhere to strict standard
operating procedures and methodologies, and to change the
WHO recommended threshold levels for the efficacy of ALB [31],
where a FEC reduction rate below 70% in the case of A.
lumbricoides or below 50% for the hookworms are the currently
accepted thresholds. We recommend that in future monitoring of
single-dose ALB-dependent control programs a minimum FEC
reduction rate (based on arithmetic means) of .95% for A.
lumbricoides and .90% for hookworms are appropriate thresholds,
and that efficacy levels below this should raise concern. The great
variability of the FECR for T. trichiura and the relatively low
efficacy of ALB, confirmed in this present study, indicate that it is
not possible to propose an efficacy threshold for this parasite based
on our data.
In conclusion, the present study is the first to evaluate drug
efficacy of a single-oral dose of ALB on such a scale and across
three continents. The results confirm the therapeutic efficacy of
this treatment against A. lumbricoides and hookworms, and the low
efficacy against T. trichiura. Efficacy varied widely across the seven
different trials, particularly in the case of T. trichiura and it remains
unclear which factors were principally responsible for this
variation, although pre-intervention FEC and age played clear
roles in this respect. The FEC reduction rate based on arithmetic
means is the best available indicator of drug efficacy, and should
be adopted in future monitoring and evaluation studies of large
scale anthelmintic treatment programs. Finally, our findings
Table 5. Fecal egg count reduction for samples with a pre-intervention FEC of more than 150 EPG.
A. lumbricoides T. trichiura Hookworms
n
FECR
(1)
(%)
FECR
(2)
(%)
FECR
(3)
(%) n
FECR
(1)
(%)
FECR
(2)
(%)
FECR
(3)
(%) n
FECR
(1)
(%)
FECR
(2)
(%)
FECR
(3)
(%)
Country
Brazil 47* 100.0 100.0 100.0 0* _ _ _ 46* 97.5 99.6 97.5
Cambodia 1* 100.0 100.0 100.0 1* 100.0 99.7 100.0 100 97.7 99.6 96.7
Cameroon 266 99.8 100.0 100.0 233 39.9 93.4 50.4 71 93.6 99.5 95.1
Ethiopia 145 100.0 99.9 100.0 72 92.3 99.2 92.6 66 99.6 99.7 99.8
India 17* 98.9 99.9 99.6 11* 72.0 99.1 87.0 83 87.8 99.3 84.2
Tanzania 266 100.0 100.0 99.9 325 58.3 86.6 36.4 281 95.4 99.7 93.1
Vietnam 130 100.0 99.9 99.9 71 93.1 99.2 88.0 19* 100.0 99.7 100.0
Age class
A (4–8) 196 99.9 100.0 99.8 153 65.1 94.8 57.2 130 94.7 99.6 94.4
B (9–12) 613 99.8 100.0 99.9 515 48.4 94.1 51.8 460 94.9 99.6 93.2
C (13–18) 63 100.0 100.0 100.0 45 60.2 94.4 46.4 76 96.4 99.6 97.1
Sex
Female 428 100.0 100.0 99.9 343 54.0 94.7 57.7 286 95.2 99.6 93.8
Male 444 99.7 100.0 99.9 370 53.0 93.8 48.0 380 94.8 99.6 94.0
Pre-intervention infection intensity
Low 582 99.9 99.9 99.9 490 49.0 95.1 50.2 613 94.1 99.6 93.6
Moderate 270 100.0 100.0 100.0 215 58.7 92.2 58.7 40 97.6 99.9 97.1
High 20 99.5 100.0 99.6 8 40.0 88.6 40.1 13 95.9 99.9 96.4
Total 872 99.9 100.0 99.9 713 53.5 94.3 52.7 666 95.0 99.6 93.9
FECR(1): group based and arithmetic mean; FECR(2): group based and geometric mean; FECR(3): individual based and arithmetic.
*Due to the low number of infected subjects (,50), the trials conducted in these countries were excluded from further analysis.
doi:10.1371/journal.pntd.0000948.t005
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emphasize the need to revise the WHO recommended efficacy
threshold for single dose ALB treatments.
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